EMS Limited Reports Q2 Margin Recovery and ₹900 Crore Orders
Key highlights
- EMS reported a 30% sequential increase in operating income in Q2 FY27.
- EMS said Q2 FY27 EBITDA and PAT each rose 50% sequentially.
- EMS secured ₹900 crore in new orders during the Q2 FY27 update.
- EMS guided for 30-35% revenue growth in both Q3 and Q4 FY27.
powered by IRIS

EMS Limited said its Q2 FY27 EBITDA and profit after tax rose 50% sequentially, alongside ₹900 crore of new orders, pointing to a recovery after monsoon-related disruption in the first half. Management also said operating income increased 30% from Q1 FY27 and guided for 30-35% revenue growth in both Q3 and Q4.
Know EMS inside out
Results, valuation, peers and who's buying, in one view.
What did EMS report for Q2 FY27?
EMS reported a 30% sequential increase in operating income and a 50% sequential increase in both EBITDA and profit after tax for Q2 FY27, compared with Q1 FY27. The figures were discussed during the company's earnings conference call for the quarter and half year ended September 30, 2026.
The Q2 update is notable because it indicates an improvement in operating and profitability metrics after a weaker first half affected by monsoon conditions. The available call highlights do not provide absolute Q2 revenue, EBITDA or PAT figures, nor do they disclose EBITDA margin percentages. The reported changes should therefore be read as quarter-on-quarter movements rather than as a complete financial statement.
EMS also disclosed that it secured ₹900 crore in new orders. The order announcement was presented alongside management's comments on the Q2 recovery and its expectations for the second half of FY27. No order-book total or detailed project-wise break-up was included in the supplied call summary.
How did the first-half disruption affect EMS?
Management attributed the first-half setback to monsoon conditions, while describing Q2 as a period of sequential recovery. The available earnings-call summary identifies the monsoon as the factor behind the H1 disruption but does not quantify the effect on project execution, revenue or margins.
For an engineering and project-execution company, timing of work and billing can influence quarterly financial performance. In this case, EMS's reported 30% increase in operating income and 50% increases in EBITDA and PAT from Q1 to Q2 show that the company recorded better sequential performance during the September quarter.
The Q2 call followed earlier investor communications by EMS. The company released the transcript of its Q1 FY27 earnings conference call, held on August 13, 2026, and subsequently disclosed the recording link for the Q2 and H1 FY27 call on November 13, 2026 under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations.
What do the new orders and growth guidance indicate?
The ₹900 crore of new orders and the 30-35% revenue-growth guidance for each of Q3 and Q4 FY27 were the central forward-looking points from the call. These disclosures provide investors with management's view of the expected pace of activity during the second half, following the monsoon-related H1 setback.
The guidance applies separately to Q3 and Q4 FY27, according to the available summary. It is management guidance rather than a reported result, and the information provided does not state a full-year FY27 revenue target, a revised margin target, or the share of new orders expected to be executed during the current financial year.
The fresh-order figure is relevant to operations because project awards form the pipeline for future execution. However, the supplied material does not provide project locations, customer names, contract durations or expected completion dates. Investors therefore have limited information from this update to assess the timing of revenue recognition from the announced orders.
Got a follow-up? Ask IRIS
How does the Q2 update compare with EMS's FY26 base?
EMS reported FY26 standalone revenue of ₹608 crore and consolidated revenue of ₹732 crore. For the fourth quarter of FY26, standalone revenue was ₹84 crore and consolidated revenue was ₹120 crore, based on the company's May 2026 earnings-call material.
These reported FY26 figures provide a financial reference point for the FY27 commentary, although they are not directly comparable with the Q2 sequential growth percentages disclosed in the latest call. The current update refers to quarter-on-quarter growth from Q1 FY27 to Q2 FY27, whereas the earlier figures are standalone and consolidated revenue amounts for Q4 and full-year FY26.
The distinction between standalone and consolidated reporting also matters when comparing periods. EMS did not provide equivalent Q2 FY27 absolute revenue data in the supplied information, so a precise year-on-year comparison cannot be made from the available disclosures.
Why does the earnings call disclosure matter to investors?
The earnings call matters because it combines reported sequential improvements with management's outlook for the remaining two quarters of FY27. A 50% sequential rise in EBITDA and PAT, coupled with ₹900 crore of new orders, gives investors data points on both the September-quarter performance and the company's stated activity outlook.
At the same time, the disclosure leaves several items unresolved. The supplied transcript highlights do not state the size of the total order book, the absolute Q2 financial results, margin levels, project mix or the status of execution affected by the monsoon. These details would be necessary to assess the durability of the reported recovery beyond the guidance provided by management.
For the broader project-execution industry, seasonal disruption remains relevant where on-ground activity can be affected by weather conditions. EMS's update shows that such disruption was part of its H1 FY27 context, while its Q3 and Q4 guidance signals management's expectation of stronger revenue growth during the second half.
Conclusion
EMS's Q2 FY27 call indicated a sequential improvement in operating income, EBITDA and PAT after monsoon-related first-half disruption. The company reported 30% growth in operating income, 50% growth in EBITDA and PAT, and ₹900 crore of fresh orders, while FY26 consolidated revenue had stood at ₹732 crore.
The key item to watch is execution against management's 30-35% revenue-growth guidance for both Q3 and Q4 FY27. Future disclosures on absolute quarterly revenue, profitability, order-book size and conversion of the newly secured orders would provide a clearer view of the second-half performance.


